Navigation Links
NCC and Wyeth Donation to Assist Cancer Patients in Latin America
Date:1/14/2009

LIMA, Peru, Jan. 14 /PRNewswire/ -- The National Cancer Coalition (NCC) and Wyeth Pharmaceuticals (Wyeth) are pleased to announce a pilot program to assist cancer patients in Latin America with donations of Wyeth's cancer-related medicines Mylotarg(TM) (gemtuzumab ozogamicin for injection) and Neumega(TM) (oprelvekin).

United States Ambassador Michael McKinley and the Peruvian Health Ministry participated in a hand-over event held at the Instituto Nacional de Enfermadades Neoplacias (INEN) in Lima, along with representatives from National Cancer Coalition, Wyeth Pharmaceuticals, INEN, and the Peruvian media. This donation to INEN, which is the largest public cancer hospital in Peru, consists of life-saving medicines valued at over $500,000.

Ambassador McKinley stated, "The event we are celebrating today is very important for several reasons. First, because this donation is the light of hope for many cancer patients in Peru who, due to the large quantity of medicines being donated today, will have access to life-saving treatment. In addition, this event is very special because it underscores the importance of public-private partnerships and the concrete gains that can be achieved with these partnerships to meet the critical health care needs of our citizens."

Eduardo Nieto, President, Wyeth Pharmaceuticals, Latin America, commented, "Wyeth is dedicated to aiding patients in need, and we are honored to be partnering with NCC in this initiative to provide oncology medicines to underserved patients in Peru."

"National Cancer Coalition is pleased that this new program with Wyeth Pharmaceuticals will lead to greater oncology resources for patients in the developing world. Through this donation, it is anticipated that over 100 Peruvian leukemia patients will be helped at INEN this year. NCC looks forward to expanding our medicine donation initiatives with Wyeth, as we jointly seek to help patients who would otherwise lack access to their required specialty medicines," stated Robert B. Landry, President of NCC. In the last five years, NCC has provided over $9 million worth of donated cancer medicines to INEN hospitals.

National Cancer Coalition, a 501(c)(3) not-for-profit corporation, supports cancer relief, research and educational programs throughout the world. The Coalition's international medical assistance program, termed NCC Cares, provides requested pharmaceuticals, medical equipment, and hospital supplies to public hospitals and local humanitarian organizations that help needy patients in over 40 developing countries around the world.

For additional information, please contact National Cancer Coalition at: 919-821-2182 or visit our website at http://www.nationalcancercoalition.org.


'/>"/>
SOURCE National Cancer Coalition
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines
2. Wyeth to Present at the JP Morgan Healthcare Conference
3. SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth Pharmaceuticals
4. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
5. Wyeth Sets Webcast and Conference Call for 2008 Fourth Quarter and Full Year Earnings
6. Wyeth to Present at the Credit Suisse Healthcare Conference
7. The Senior Citizens Leagues Comments on U.S. Supreme Court Case Wyeth v. Levine
8. Wyeth v. Levine: Preemption and The Facts
9. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
10. Wyeth Selected for 11th Consecutive Year as One of Working Mother Magazines 100 Best Companies for Working Mothers
11. Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... ... Miami native and local periodontist Dr. John Paul Gallardo is celebrating ... 1991 that this journey would have taken me into so many learning experiences both ... has pioneered implant dentistry innovation, evolving into an internationally recognized leader in the industry. ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced ... farmers produce more and better food, with fewer resources. It highlights the business’ ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a ... first in a new class of photodynamic cosmetics (PDC). , Allumera® is the ... reduce outward signs of aging, and minimize the appearance of pores – all ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... agreement to be the preferred physical therapy provider for Derby City CrossFit, effective ... Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology: